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The amino acid sequence has been determined for the major protein that accumulates in amyloid fibrils 
in tissues of the Pekin duck. With the exception of 16 residues at the amino terminus, this 106-residue prote- 
in is homologous with human serum amyloid protein A (104-residue apoSAA), which is the putative precur- 
sor of the 76-residue protein that accumulates in human patients with amyloidosis. Duck serum is shown 
to contain aprotein that is immunologically related and approximately equal in size (12 kDa) to the deposit- 
ed form in ducks. These results indicate that proteolytic processing of the precursor isnot a necessary step 
in the deposition of amyloid fibrils, at least in the duck. 
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1. INTRODUCTION 
The distinguishing feature of reactive, secondary 
amyloidosis in man and other species is the ex- 
tracellular accumulation in various tissues of a 
9 kDa protein termed amyloid protein A (AA) 
[1,2]. its putative precursor in humans, the 12 kDa 
HDL-associated, acute-phase protein SAA, is 28 
residues longer at the carboxyl-terminus [3]. 
Although it is generally assumed that proteolytic 
removal of the carboxyl-terminal segment is re- 
quired for the deposition of protein AA as amyloid 
fibrils, Pekin ducks have been found to ac- 
cumulate in their tissues a protein that exhibits ize 
and partial sequence similarity [4,5] to the precur- 
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sor form in human HDL particles and to proteins 
predicted from the cDNA sequences of murine 
SAA [6,7]. The present study completes the amino 
acid sequence determination of the major protein 
of Pekin duck amyloid fibrils, enabling com- 
parisons with AA-related proteins from other 
species, and obviating the assumption that pro- 
teolytic digestion of the precursor is necessary for 
the deposition process. 
2. MATERIALS AND METHODS 
Duck liver tissue was generously supplied by Dr 
R.H. Rigdon (University of Texas Medical 
Branch, Galveston), who has described the spon- 
taneous occurrence of amyloidosis in white Pekin 
ducks [8]. The amyloid protein was extracted and 
partially purified by procedures used for the isola- 
tion of human protein AA [9]. After removal of 
two high-Mr contaminants on a 2.5 × 115 cm 
Sephadex G-50 column in 9070 HCOOH, the major 
component (12 kDa) was lyophilized. 
The protein was cleaved at methionyl bonds with 
cyanogen bromide [10]. The largest fragment, M3, 
was subdigested with trypsin at arginyl residues, 
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with Staphylococcus aureus V8 protease (Miles) at 
glutamyl residues [3], and with 70070 formic acid 
(57°C, 18 h) at a single Asp-Pro  bond. 
Fragments generated with cyanogen bromide 
were separated on a Sephadex G-25 column (2.5 x 
110 cm) in 9070 formic acid [10]. Other peptides 
generated by subdigestion were purified by HPLC 
using TSK G3000SW and SynChropak RP-P col- 
umns with acetonitrile gradients in dilute aqueous 
trifluoroacetic acid [3]. 
Amino acid compositions were determined using 
a Dionex D550 amino acid analyzer following the 
manufacturer's specifications or with a Waters 
Picotag system [11]. Sequences were analyzed with 
a Beckman 890B or 890M sequencer in the 
presence of polybrene [12] and each phenylthiohy- 
dantoin was identified in two different HPLC 
systems [13-15]. 
Serum with an elevated SAA level, as deter- 
mined by radioimmunoassay [16], was obtained 
from a member of a locally maintained flock of 
Pekin ducks that, 17 months previously, had been 
injected with a homogenate of amyloidotic duck 
liver [4]. The serum was fractionated by sequential 
centrifugation at densities of 1.06, 1.13, and 
1.21 g/ml. Flotation layers collected at each densi- 
ty correspond to VLDL + LDL, HDL2, and 
HDL3, respectively. These three layers and the bot- 
tom layer of density > 1.21 were dialyzed against 
0.85°70 NaCl/0.01 M phosphate, pH 7.4, then ex- 
amined by Western blot using rabbit antiserum to 
duck protein AA and 125 I-staphylococcal protein A 
[17]. 
SEARCH and AL IGN programs [18] were used 
with the August 13, 1986 protein database files of 
the National Biomedical Research Foundation. 
Table 1 
Amino acid compositions a 
Fragment: Protein Ml M2 M3 R3 
Residues: 1-106 1-21 22-28 29-106 100-106 
Ala (A) 16.7 (17) 3.1 (3) 1.1 (1) 
Arg (R) 15.0 (15) 2.0 (2) 1.9 (2) 
Asx(D+N) 16.7 (10+7) 3.7 (3+1) 1.2 (1+0) 
Glx (E + Q) 6.0 (4 + 2) 
Gly (G) 18.0 (17) 4.0 (4) 
His (H) 1.9 (2) 
Ile (I) 1.9 (2) 
Leu (L) 3.2 (3) 1.0 (1) 1.0 (1) 
Lys (K) 1.2 (1) 
Met (M) 1.9 (2) 0.6 (1) 1.0 (1) 
Phe (F) 3.1 (3) 1.8 (2) 
Pro (P) 6.0 (6) 0.9 (1) 
Ser b (S) 2.8 (2) 
Thr b (T) 2.0 (2) 0.8 (1) 
Trp (W) N.D. (4) N.D. (1) 
Tyr (V) 4.3 (4) 0.9 (1) 
Val (V) 3.2 (3) 1.0 (1) 
Number of 
residues (106) (2 l) (7) (78) (7) 
13.1 (13) 
11.0 (11) 1.0 (1) 
11.8 (6+6) 
5.7 (4+2) 
14.0 (13) 1.5 (1) 
1.6 (2) 
1.9 (2) 
1.0 (1) 1.0 (1) 
1.1 (l) 
1.0 (1) 




2.7 (3) 0.8 (1) 
2.2 (2) 
a Residues/molecule by amino acid analysis or (in parentheses) from the sequence. 
Hydrolysis for 20 h (115°C, 6 N HC1) with a crystal of phenol and 0.050/0 
mercaptoethanol 
b Ser increased by 10070, Thr by 5070 to compensate for destruction by acid 
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Fig. 1. Summary of the proof of sequence. The sequences of specific peptides (peptide acronyms are underlined) are 
given in one-letter code below the summary sequence (bold type). Prefixes M, E and R denote peptides generated by 
cleavage of M3 at the carboxyl side of Met, Glu and Arg, respectively. AC denotes a peptide resulting from acid cleavage 
of M3. Arrows denote a longer unidentified sequence. Lower-case letters indicate residues tentatively identified or 
placed by composition of the peptide. 
Alignment scores are expressed in standard evia- 
tion units from a random score [18]. 
3. RESULTS 
The results of Edman degradation of the intact 
protein and eight peptides derived therefrom are 
summarized in fig. 1. Together these nine analyses 
provide a set of overlapping data that delineates 
the sequence of the 106-residue protein. The 
molecular mass calculated from the sequence is 
11587 Da. 
Fragmentation at the two methionyl residues 
(table 1) provided a fragment, M3 (residues 
29-106), which, upon Edman degradation, yielded 
a sequence that overlapped the amino-terminal se- 
quence of the intact protein and extended the 
structure to Ser-74. After cleavages at glutamyl or 
arginyl residues in M3, six peptides were isolated 
(E l -E3  and R1-R3, respectively). Edman 
degradation of these peptides extended the se- 
quence to the carboxyl-terminal residue, Pro-106 
(fig.l). 
The only tryptic peptide lacking a carboxyl- 
terminal arginine was R3; hence, it must be the 
carboxyl-terminal tryptic peptide of the protein. 
Confirmation of the carboxyl-terminal sequence 
was provided by the sequence of AC1, a peptide 
obtained by acid cleavage of M3 at an Asp-Pro  
bond. Both the intact protein and M3 were resis- 
tant to digestion by carboxypeptidase Y, possibly 
due to aggregation or to the high proline content of 
this region. 
Coomassie staining after electrophoresis of the 
HDL3 fraction from Pekin duck serum revealed 
two faint bands in the 12 kDa region (fig.2A), only 
one of which reacted with antibody to duck protein 
AA (fig.2B). The mobility of the immunopositive 
band was virtually identical to those of duck AA 
and of human apoSAA1. Similarly located im- 
munopositive bands were seen in the elec- 
trophoretic patterns of (VLDL + LDL), HDL2, 
and the layer of greatest density (not shown); the 
latter also exhibited faintly immunopositive bands 
in association with dye-stained bands at approx. 
30, 50 and 70 kDa. 
4. DISCUSSION 
The present sequence analysis of Pekin duck 
amyloid protein A completes the structure of the 
protein and shows it to be homologous throughout 
much of its length to human and murine precursor 
forms (fig.3). The earlier report of a partial se- 
quence by Gorevic et al. [5] had suggested 
heterogeneities at residues 33, 34 and 63, but none 
of these was observed in the present analysis. Their 
tentative assignment of Ala-Arg or Ser-Arg to the 
C-terminus was based on carboxypeptidase 
digests, and is at variance with our sequence data. 
However, endopeptidase contamination is a com- 
mon problem in such digests. Their estimate of a 
13 
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Fig.2. Electrophoretic/immunologic comparison of 
duck AA and duck HDL3 with human apoSAA1 and 
human trauma HDL3; arrow indicates direction of 
migration. (A) SDS-polyacrylamide g l (11%) stained 
with Coomassie blue R-250: (1) HDL3 from -10/zl 
human trauma serum (see [17]); (2) human apoSAAl, 
-1/zg; (3) HDL3 from -30/zl duck serum; (4) duck AA, 
-2/zg. Intrinsic markers in sample of human HDLa are 
apolipoprotein A-I (28 kDa), apolipoprotein A-II 
(17 kDa), and apoSAAl (12 kDa). (B) Autoradiograph 
of samples as in (A), after Western blotting using rabbit 
antisera to duck or human protein AA. 
molecular mass of 12000 Da (from SDS gels) is 
very close to the value of 11 587 Da calculated 
from our sequence. 
A search of the protein databank for 
homologous equences revealed only amyloid A 
proteins and their precursors in other animal 
species. Alignment scores of 14.7 to 18.2 standard 
deviation units [18] indicate extensive similarity 
among these mammalian and duck proteins in 
spite of approx. 300 million years of divergence. 
As shown in fig.3, the regions of greatest identity 
are in the middle of the precursor forms (residues 
37-68, using the numbering of the human pro- 
tein). The small difference of three residues at the 
carboxyl-terminus could reflect a minor post- 
translational proteolytic digestion of the duck pro- 
tein, but its DNA sequence would be necessary to 
clarify this point. 
The amino-terminal 16 residues of the duck pro- 
tein do not resemble their mammalian counter- 
parts (alignment scores < 1) although the latter are 
quite similar to each other (fig.3). This region in 
murine AA corresponds to the second of four ex- 
ons [7] and its lack of homology with the duck pro- 
tein may suggest a unique or rapidly mutating exon 
encoding this region of the duck protein. A search 
of the sequence database detected no homologous 
segment. 
The deposited form of human protein AA is 28 
residues horter at the carboxyl-terminus than the 
circulating form of the SAA protein [3]. A similar 
difference between deposited and circulating forms 
exists in the mouse [21]. Amyloid fibrils in monkey 
and mink contain homologous proteins with 
similar or shorter C-termini (fig.3), but the 
presumed precursor forms have not been studied. 
It is generally assumed that the deposition event 
and the proteolytic removal of the carboxyl- 
terminus from a circulating precursor are in some 
way interdependent. However, the present study 
weakens that hypothesis because the longer rather 
than the shorter form is deposited in the amyloid 
fibrils of the duck. Small amounts of SAA-like 
molecules have also been detected in human 
amyloid deposits [22]. Although the putative 
precursor in the duck has not been studied in 
detail, the evidence in fig.2 indicates that the cir- 
culating form resembles human SAA in mass and 
may well be identical with the deposited form in 
the duck. 
The alignment in fig.3 shows that human 
amyloid fibrils contain protein cleaved between 
Ser-76 and Leu-77, although Moyner et al. [23] 
have reported a slightly longer (but tentative) 
structure from a patient with Waldenstr6m's 
macroglobulinaemia. This site of cleavage is just 
C-terminal to an amphipathic helical region 
predicted to end at residue 74 [3]. It is not clear 
what protease degrades the amyloid precursor 
SAA to the fibrillar AA deposit in humans, 
monkey, mouse or mink. Nor is it possible to state 
whether the lack of proteolytic leavage in the 
duck is due to the lack of a protease or to a dif- 
ference in structure of the precursor itself, for ex- 
14 
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Fig.3. Comparison of Pekin duck liver amyloid protein A with serum precursors (SAA) in man and mouse, and with 
amyloid fibrillar deposits (AA) in monkey and mink. The number system corresponds to the human precursor [3]. 
Residues identical with the duck protein are boxed (circled residues are excluded from the box). Hyphens denote gaps 
to optimize homology; <Q symbolizes a pyrollidone carboxyl residue. An asterisk indicates the C-terminus of the 
deposited fibrillar form in man [19,20]. Sequences have been determined on the protein unless noted otherwise. 
a Isolated from HDL. A variant with Ala-52 and Val-57 was also seen [3]. Other variants have been reported in patients 
with familial Mediterranean fever [20] and with Waldenstr6m's macroglobulinaemia [23]. b Derived from murine liver 
library cDNA sequence [6]. Two other variants, SAA~ and SAA3, have also been reported [6,7]. c Isolated from Macaca 
mulatta liver [10]. d Isolated from mink liver [24]. 
ample, at the unique Arg-77 (human numbering) in 
fig.3. Whatever the explanation, it is not necessary 
to invoke a proteolytic leavage in the process of 
deposition of amyloid fibrils in the Pekin duck. 
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